Immedica Pharma
Healthcare
HQ: Stockholm, Sweden
Investors: 1
Leading pan-European pharmaceutical platform based in Sweden and focused on in-licensing late-stage niche orphan disease assets for commercialization primarily in Europe.
Leading pan-European pharmaceutical platform based in Sweden and focused on in-licensing late-stage niche orphan disease assets for commercialization primarily in Europe.